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Genome-wide association studies have identified variants within the FTO (fat mass and
obesity associated) locus as the strongest predictors of obesity amongst all obesity-associ-
ated gene loci. Recent evidence suggests that variants in FTO directly affect human adipo-
cyte function through targeting IRX3 and IRX5 and thermogenesis regulation.
Aim
We addressed the relevance of this proposed FTO-IRX pathway in adipose tissue (AT) of
children.
Results
Expression of IRX3 was higher in adipocytes compared to SVF. We found increased adipo-
cyte-specific expression of IRX3 and IRX5 with the presence of the FTO risk haplotype in
lean children, whereas it was unaffected by risk variants in obese peers. We further show
that IRX3 expression was elevated in isolated adipocytes and AT of lean compared to
obese children, particularly in UCP1-negative adipocytes, and inversely correlated with BMI
SDS. Independent of BMI, IRX3 expression in adipocytes was significantly related to adipo-
cyte hypertrophy, and subsequent associations with AT inflammation and HOMA-IR in the
children.
Conclusion
One interpretation of our observation of FTO risk variants linked to IRX3 expression and adi-
pocyte size restricted to lean children, along with the decreased IRX3 expression in obese
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compared to lean peers, may reflect a defense mechanism for protecting body-weight,
which is pertinent for lean children.
Introduction
Genetic variants in the FTO (fat mass and obesity associated) gene have been discovered and
repeatedly confirmed to pose the strongest (poly)genetic risk for human obesity [1–3]. Multiple
studies have focused on deciphering potential mechanisms, by which variants within a region
of high linkage disequilibrium in introns 1 and 2 of FTO confer the obesity risk.
Initial observations that fasting is associated with decreased hypothalamic Fto expression
and that manipulations in hypothalamic Fto expression affect food intake in mice [4] suggested
a central mode of action for FTO. In humans, presence of the risk genotype only subtly modu-
lated the amount and/or the preferences of ingested food [5, 6]. Studies in Fto knockdown mice
showing reduced adipose tissue (AT) mass despite hyperphagia or unaltered food intake but
increased energy expenditure [7, 8] questioned whether the susceptibility alleles and FTO con-
vey their effects entirely in the brain and point to the adipose tissue itself as a potential target.
Very recently, Claussnitzer et al. delineated a new mechanism whereby variants in the FTO
gene affect human adipocyte function through targeting IRX3 and IRX5 [9]. The potential
functional link between FTO and IRX3 is supported by evidence from murine, human, and in
vitro studies showing that the IRX3 promoter strongly interacts with the obesity-associated
interval within FTO, and that obesity-linked SNPs are associated with IRX3 but not with FTO
expression [10, 11]. Knockout of Irx3 in mice led to a significant reduction in body weight,
increased activation of brown AT and increased energy expenditure [11]. In the human study,
the causal rs1421085 variant resulted in the activation of IRX3 and IRX5 expression during
early adipocyte differentiation and a developmental shift from energy-dissipating beige adipo-
cytes to energy-storing white adipocytes [9] and thereby may contribute to the predisposition
for obesity, even though the study was restricted to lean healthy adults.
Within this study, we aimed to assess whether the link between the FTO risk genotype and
IRX3 and IRX5 expression in AT is related to the development of obesity and to alterations of
AT biology in children.
Materials and Methods
Subjects and samples (Leipzig Childhood Adipose Tissue cohort)
Subcutaneous AT samples from 45 lean and 47 overweight and obese children included in the
previously described Leipzig Childhood Adipose Tissue cohort [12] were obtained during elec-
tive surgery. Children underwent detailed anthropometric, clinical and metabolic assessments
[12]. The study was approved by the ethics committee of the Medical Faculty, University of
Leipzig (Reg.No: 265-08-ff; NCT02208141) and written informed consent was obtained from
all parents.
Preparation of and analyses of AT samples was performed according to previously pub-
lished protocols [12]. Briefly, adipocytes and stromal vascular fraction (SVF) were isolated by
collagenase digestion and adipocyte diameter was determined after osmium fixation using a
Coulter counter (Multisizer III; Beckmann Coulter). Macrophage infiltration was analysed by
immunohistochemical staining of AT sections with CD68 antibody (M0718, DAKO).
Prior to surgery, fasting blood samples were obtained and stored at -80°C. Analyses of
serum parameters (adiponectin, leptin, high sensitivity C-reactive protein (hsCRP), glucose
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and insulin) were performed by a certified laboratory (Institute of Laboratory Medicine, Clini-
cal Chemistry and Molecular Diagnostics, University of Leipzig).
DNA-Isolation and genotyping
DNA from EDTA blood samples was isolated using the QIAmp DNA Blood MiniKit (Qiagen).
Samples were genotyped as part of the LIFE Child study (43 plates comprising 4,128 samples)
using the Affymetrix Axiom Genome-Wide CEU 1 Array. Sample quality control included
dish-qc> = 0.82, call rate> = 97%, sex-mismatches, implausible relatedness and outliers of
principal components analysis. Duplicates and controls were removed resulting in a total of
3,797 successfully genotyped samples. SNP quality control was passed with cluster plot criteria
of Affymetrix, call rate97%, p-value of Hardy-Weinberg disequilibrium test>10−6 and
plate-association p-value>10−7 in 541.835 autosomal SNPs. Data were imputed on the
1000Genomes reference panel (phase 1, release V3 of CEU, HG19, dbSNP-build 135) using
SHAPEIT Version v2.r778 with standard settings for European populations and IMPUTE2,
version 2.3.0.
According to Claussnitzer et al., participants were grouped into risk-, heterozygous, or non-
risk-allele carries depending on their genotype for the FTO obesity variants rs9930506,
rs1421085 (directly genotyped) and rs1558902 (imputed) [9].
RNA isolation and mRNA expression analyses
RNA isolation and cDNA synthesis from whole AT samples, isolated adipocytes or SVF cells
was performed as previously described [12]. IRX3 and IRX5 expression levels were determined
by quantitative real-time RT-PCR using SYBR green. UCP1 expression was determined as
described [13]. Expression levels were normalized to the reference genes TBP, ACTB and
HPRT [14]. Primer and probe sequences are listed in S1 Table.
Protein isolation and immunoblot analyses
Protein isolation was performed using TRIzol Reagent (Thermo Fisher Scientific) according to
the manufacturer’s instructions. Equivalent amounts of proteins were resolved by 10%
SDS-PAGE and immunoblotting using antibodies against IRX3 (abcam, ab174307) and beta-
ACTIN (abcam, ab8227).
Statistical analyses
All statistical analyses were performed using the Statistica 10.0 software package (StatSoft).
Before analyses, normal distribution of the data was assessed by Shapiro-Wilks W test and
quantile quantile plots. Non-normally distributed data were log-transformed before analyses.
Quantitative traits were analysed using parametric tests (Pearson correlation analysis, Student's
t test, one-way ANOVA with Dunnett’s post-hoc test). Categorical variables were analysed by
chi square test. For statistical analyses, overweight and obese children were combined. For mul-
tiple regression analyses, the stepwise forward model was employed.
Results
General characteristics of patients and samples of the Leipzig Childhood AT cohort included
in this study are summarized in Table 1. As previously described we detected characteristic
obesity-related alterations in AT and serum parameters, such as hypertrophy and inflamma-
tion [12].
FTO Variants and IRX3 Adipocyte Expression in Children
PLOS ONE | DOI:10.1371/journal.pone.0161739 August 25, 2016 3 / 10
We first evaluated potential differences in IRX3 and IRX5 expression in lean and obese chil-
dren. Considering that obese children are slightly older compared to lean children and, hence,
show a more advanced pubertal stage, we analyzed the effect of pubertal stage on IRX3 and
IRX5 expression in SVF cells, adipocytes and whole AT of lean children. We did not detect sig-
nificant puberty-related alterations in IRX3 and IRX5 expression (S1 Fig). If FTO variants con-
fer obesity risk by driving the expression of IRX3 [9], one may expect increased expression of
IRX genes in obese subjects. However, IRX3 expression was unchanged in SVF of obese chil-
dren and appeared to be even lower in whole adipose tissue samples and isolated adipocytes of
obese compared to lean children (Fig 1A). IRX5 expression was not different between lean and
obese children. Concordantly, adipocyte IRX3 expression negatively correlated with BMI SDS
(R = -0.265, P = 0.016), which was not found for IRX5.
As this observation may point to potentially distinct regulation in AT subfractions, we com-
pared IRX3 and IRX5 expression in whole adipose tissue and freshly isolated SVF cells and adi-
pocytes. We detected highest expression of both IRX3 and IRX5 in adipocytes (Fig 1A).
To evaluate whether the IRX expression might be genetically driven by FTO risk variants,
we next assessed the expression of IRX3 and IRX5 according to FTO risk haplotype. Only in
the lean subcohort, adipocyte-specific expression of both IRX3 and IRX5 was increased in risk-
allele carriers compared to nonrisk-allele carriers, which was not observed in obese children
(Fig 1B) similar to what was found in lean adults [9]. In line with Claussnitzer et al. we did not
detect differences in IRX3 and IRX5 expression between genotype groups in whole AT or SVF
(Fig 1C and 1D).
Table 1. Characteristics of the Childhood Adipose Tissue Cohort (n = 92).
Lean Obese
n Mean±SEM Range n Mean±SEM Range p
Anthropometric parameters
Male/Female (% male) 20/25 (44.4) 18/29 (38.3) 0.549
Age [years] 45 10.0±0.8 1.1–18.3 47 13.3±0.5 4.8–18.4 <0.001
PH 40 2.5±0.3 1–6 45 3.4±0.2 1–6 0.011
BMI SDS 45 -0.1±0.1 -2.4–1.1 47 2.5±0.1 1.4–4.3 <0.001
Adipose tissue parameters
Adipocyte diameter [μm] 25 111.9±2.4 90.9–131.2 33 125.8±2.4 98.0–146.2 <0.001
Macrophage infiltration
Macrophages per 100 adipocytes 37 11.1±1.4 0–29 39 20.5±3.4 0–115 0.031a
CD68mRNA in SVF 36 0.6±0.1 0.1–1.7 32 1.3±0.2 0.0–3.8 <0.001a
Serum parameters
Adiponectin [mg/l] 34 10.9±1.3 3.7–43.8 38 5.7±0.4 1.7–11.7 <0.001a
Leptin [ng/ml] 30 5.1±0.8 0.4–17.5 38 31.0±3.3 1.3–83.6 <0.001a
hsCRP [mg/l] 34 0.6±0.1 0.3–3.2 38 1.9±0.3 0.3–9.9 <0.001a
HOMA-IR 34 1.4±0.2 0.1–5.6 37 4.0±0.3 0.6–8.2 <0.001a
Genetic parameters
FTO haplotype(nonrisk/heterozygous/risk) 14/14/7 7/16/11 0.188
Data are given as mean ± SEM. For gender and FTO haplotype, statistical significance was analysed by chi square test. Statistical significance for
differences between groups was determined by Students t-test. Significant p-values are indicated in bold. PH, pubertal stage; BMI, body-mass index; SDS,
standard deviation score; SVF, stroma-vascular fraction; hsCRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment of insulin
resistance.
aStatistical analyses were performed for log-transformed parameters.
doi:10.1371/journal.pone.0161739.t001
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Fig 1. Expression of IRX3 and IRX5 in adipose tissue of children and association with FTO risk
haplotype and withUCP1 expression. Adipocyte and whole AT expression of IRX3was reduced in obese
compared to lean children (A). Adipocyte-specific expression of IRX3 and IRX5was significantly increased in
lean children carrying the FTO risk haplotype compared to lean children carrying the nonrisk haplotype (B).
There were no alterations in IRX3 and IRX5 expression between FTO haplotype groups in SVF (C) or whole
AT (D) of lean children. Obese children did not show differences in IRX3 and IRX5 expression levels between
FTO haplotype groups in any of the analyzed tissues (B-D). Significant differences between FTO nonrisk
versus risk haplotype groups were assessed by Student’s t-test and significant p-values are indicated in the
barplots.
doi:10.1371/journal.pone.0161739.g001
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Considering that IRX3 and IRX5 expression were directly linked to mitochondrial thermo-
genesis and negatively associated with the expression of thermogenic genes [9], we were inter-
ested in the existence of a similar link in adipocytes of children. When we stratified our
samples into UCP1-negative and UCP1-positive (depending on detectable UCP1 expression),
we found increased expression of IRX3 in UCP1-negative compared to UCP1-positive adipo-
cytes of lean children, while there was no difference in IRX3-expression in obese children (Fig
2A). Again, we did not find any alterations in IRX5 expression according to UCP1-expression
in lean nor in obese children (Fig 2A). Quantitatively, neither IRX3 nor IRX5 expression corre-
lated with UCP1 expression in UCP1-positive adipocytes.
Finding IRX3mRNA (Fig 1A) and protein (Fig 2B) expression decreased in adipocytes of
obese children, we further evaluated whether IRX3 expression may also be related to obesity
related AT alterations. Indeed, IRX3 expression in adipocytes negatively correlated with obe-
sity-related parameters of AT dysfunction, i.e. adipocyte diameter (Fig 2C) and AT inflamma-
tion as indicated by the number of infiltrating macrophages (Fig 2D) and CD68mRNA
expression in the SVF (Fig 2E). These correlations withstood adjustment for BMI SDS and age
of children in partial correlation analysis (adipocyte diameter: Radj = -0.358, p = 0.006; macro-
phage number: Radj = -0.254, p = 0.041; CD68 expression in SVF: Radj = -0.371, p = 0.008).
Moreover, we detected significant associations of adipocyte IRX3 expression with adiponectin
(Fig 2F) and leptin (Fig 2G) serum levels and with HOMA-IR (Fig 2H) as a measure of insulin
resistance, which were, however, lost after adjustment for BMI SDS and age. All of these corre-
lations were independent of pubertal development, which has a major impact on insulin resis-
tance (S2 Table).
Finally, we performed multiple regression analyses to determine the main predictors for adi-
pocyte IRX3 and IRX5 expression in AT of children. Adipocyte diameter and the FTO risk hap-
lotype independently determined adipocyte IRX3 expression accounting for 12 and 6% of
variability. For IRX5 expression, the FTO risk haplotype was not predictive (Table 2).
Discussion
In this study, we have addressed the relevance of the proposed FTO-IRX pathway in AT sam-
ples of children. Our findings of increased adipocyte-specific expression of IRX3 and IRX5
with the presence of the FTO risk haplotype in lean individuals not only complement those of
the previous study, which was restricted to lean adults. Moreover, we show higher expression
levels of IRX3 and IRX5 in adipocytes compared to SVF and we further show that IRX3 expres-
sion is elevated in AT and isolated adipocytes of lean compared to obese children and nega-
tively correlates with BMI SDS. Independent of BMI, IRX3 expression in adipocytes was
significantly related to adipocyte hypertrophy, which may explain subsequent associations
with AT inflammation and parameters of insulin resistance.
Claussnitzer et al. performed studies in adipocytes of lean adult humans and delineated the
activation of two genes near the FTO locus, IRX3 and IRX5, during early adipocyte differentia-
tion as a new mechanism conferring genetic obesity risk whereby variants in FTO directly affect
adipocyte function [9]. We provide evidence that this link between FTO risk variants and
IRX3/5 expression is already active in children. Nevertheless, this proposed FTO-IRX associa-
tion may be restricted to lean subjects as indicated by increased IRX3 and IRX5 expression in
adipocytes of lean children (and adults) carrying the FTO risk haplotype, whereas it was unaf-
fected by risk variants in obese children. In contrast to our study, previous studies did not ana-
lyze IRX expression or a potential association of FTO risk variants with IRX expression in AT
of obese patients. It would, hence, be interesting whether the proposed FTO-IRX association is
restricted to lean adults similar to what we have seen in children.
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According to Claussnitzer et al., enhanced expression of IRX3 and IRX5 results in a shift
from white adipocyte browning to lipid storage [9]. In line with these data we observed
increased IRX3 expression in UCP1-negative adipocytes compared to UCP1-positive adipo-
cytes, but we did not observe an association of IRX5 and UCP1 expression in adipocytes of chil-
dren indicating that IRX3might be the main mediator of obesity risk in FTO risk variant
carriers in children.
Fig 2. Adipocyte IRX3 expression is associated with obesity-related alterations in AT and related clinical traits.
Expression of IRX3 but not IRX5was significantly lower inUCP1-positive (18 lean, 19 obese) comparedUCP1-negative
adipocytes (21 lean, 23 obese) derived from lean, but not of obese children (A). Significant differences betweenUCP1-
positive versusUCP1-negative adipocyte samples were assessed by Student’s t-test and p-values are indicated in the
barplots. Protein levels of IRX3 are reduced in adipocyte of obese (n = 4) compared to lean (n = 3) children (B).
Expression of IRX3 in adipocytes of children was associated with adipocyte diameter (C), macrophage infiltration as
indicated by the number of adipocytes in AT (D) andCD68 expression in the stroma-vascular fraction (E), adiponectin (F)
and leptin (G) serum levels, as well as HOMA-IR as a measure insulin resistance (H). Pearson correlation coefficient R
and p-value are given in each scatter plot. Significant p-values (p<0.05) are indicated in bold.
doi:10.1371/journal.pone.0161739.g002
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Concluding from the observed association of IRX3 expression with FTO obesity risk variants
andUCP1 expression in adipocytes of lean children, one may expect increased IRX3 expression in
obese subjects. However, IRX3 expression was even lower in isolated adipocytes of obese com-
pared to lean children and correlated with obesity-related measures of adipocyte hypertrophy and
inflammation. Interestingly, adipocyte diameter was the strongest independent predictor of adipo-
cyte IRX3 expression. An interpretation for this and Claussnitzer´s finding of an IRX-dependent
shift from energy consumption to energy storage in adipocytes may be the protection of body
weight under circumstances of limited energy supply. Similar hypotheses have been discussed for
downregulation of leptin levels to signal energy insufficiency [15]. Interestingly, obesity-associated
FTO risk alleles have been discussed as candidate thrifty alleles, which have been driven to high
frequency by positive selection [16]. According to the thrifty gene hypothesis, populations whose
ancestral environments were characterized by alternating periods of food abundance and food
shortage experienced positive selection for alleles that promote storage of fat in order to provide a
survival advantage [17]. Such defense mechanisms for preserving body weight would be pertinent
for lean subjects, particularly children, and may be attenuated in the obese state.
One strength of our study is that we provide data on whole AT as well as freshly isolated
SVF cells and adipocytes of humans, which might be closer to physiological conditions com-
pared to analyses performed in cell cultures of primary cells. However, we are limited by the
often small sample volumes in children, which precluded more mechanistic analyses.
In conclusion, our results indicate a relationship between FTO variants and IRX3 expression
and adipocyte phenotype in lean children, which is attenuated in the obese state.
Supporting Information
S1 Fig. Expression of IRX3 in AT of lean children and association with puberty stage. There
were no significant differences in IRX3 and IRX5 expression in SVF cells, adipocytes or AT
between pre-pubertal, pubertal and post-pubertal children. Differences between puberty stages
were assessed by one-way ANOVA and Dunnett’s post-hoc test. A P-value of less than 0.05
was considered significant. SVF, stroma-vascular fraction. AT, adipose tissue.
(TIF)
S1 Table. Primer and probe sequences for quantitative real-time RT-PCR.
(DOC)
Table 2. Multiple regression analyses for predictors of adipocyte IRX3/5 expression.
Step Parameter Delta R2 Beta ± SEM p
independent variables for all models:
age, gender, PH, BMI SDS, adipocyte diameter, Log macrophage number, FTO haplotype
dependent variable: IRX3 expression in adipocytes (R2 = 0.30, p = 0.002, n = 44)
1 adipocyte diameter 0.12 -0.42±0.14 0.005
2 FTO haplotype 0.06 -0.29±0.14 0.038
3 Log macrophage number 0.12 -0.23±0.14 0.110
dependent variable: IRX5 expression in adipocytes (R2 = 0.26, p = 0.019, n = 44)
1 adipocyte diameter 0.39 -0.48±0.18 0.010
2 BMI SDS 0.33 0.37±0.17 0.035
3 age 0.20 0.28±0.15 0.073
4 Log macrophage number 0.11 -0.16±0.15 0.273
PH, pubertal stage; BMI, body-mass index; SDS, standard deviation score. Significant p-values (p<0.05) are indicated in bold.
doi:10.1371/journal.pone.0161739.t002
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S2 Table. Comparison of unadjusted and puberty-adjusted correlations of adipocyte IRX3
with obesity-related patient parameters.
(DOC)
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